ENDONOVO THERAPEUTICS, INC. (ENDV) Operating cash flow 2013–2022
ENDONOVO THERAPEUTICS, INC. (ENDV) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$678,838FY2022 · since FY2013: -$257,416 → -$678,838
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$678,838 | +31.2% |
| FY2021 | -$986,584 | -33.0% |
| FY2020 | -$741,590 | +70.8% |
| FY2019 | -$2.5M | +11.7% |
| FY2018 | -$2.9M | +3.7% |
| FY2017 | -$3.0M | -21.4% |
| FY2016 | -$2.5M | -141.6% |
| FY2015 | -$1.0M | -12.1% |
| FY2014 | -$909,296 | -253.2% |
| FY2013 | -$257,416 | — |
Source: SEC XBRL filings · For reference only · Not investment advice